Skip to main content

Table 1 Demographic and biomarker information for subjects from Emory and ADNI

From: CSF complement 3 and factor H are staging biomarkers in Alzheimer’s disease

 

ADNI

Emory

 

MCI (n = 135)

AD (n = 95)

MCI (n = 51)

AD (n = 22)

Male (%)

86 (64 %)

53 (56 %)

28 (55 %)

6 (27 %)

Age (S.D.), yr

74.7 (7.6)

74.3 (7.7)

69.0 (7.4)

65.6 (8.8)

Education (S.D.), yr

15.8 (2.9)

14.9 (3.1)

15.4 (2.5)

13.9 (2.4)

Having at least one APOE4 allele

86 (64 %)

67 (70 %)

25 (49 %)

8 (36 %)

CSF

    

Aβ42 (pg/mL)

136.7 (31.4)

143.5 (39.9)

129.8 (55.3)

168.3 (104.0)

t-Tau (pg/mL)

122.8 (60.6)

122.5 (57.8)

97.7 (49.6)

120.3 (60.0)

p-Tau181 (pg/mL)

42.4 (16.1)

41.4 (19.9)

55.6 (25.7)

61.1 (26.2)

FH (pg/mL)

1568 (629)

1750 (835)

1594 (493)

1692 (474)

Z-score, log(C3)

−0.060 (0.929)

0.061 (1.084)

−0.481 (1.031)

−0.064 (0.784)

  1. MCI: mild cognitive impairment with CSF t-Tau/Aβ42 ≥ 0.39; AD: mild dementia due to Alzheimer's disease